Skip to main content
. 2012 Jan 12;14(2):247–256. doi: 10.3109/14653249.2011.629645

Figure 6.

Figure 6.

The average change in score (positive mean improvement) in VAS on pain score from baseline until 12 months (M12). On average, patients showed a decrease in pain with all three dose levels, with a marked improvement with dose level 3 at 3 months with a regression at 6 months.